The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile-Reference-Cited by-同舟云学术

The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile

Published:2008-03 Issue:2 Volume:14 Page:295-302
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

GRENINGER D. A.,SAINT-REMY J. M.,JACQUEMIN M.,BENHIDA A.,DIMICHELE D. M.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2007.01620.x/fullpdf

Reference32 articles.

1. Attempts to make sense of the antiphospholipid syndrome

2. The North American Immune Tolerance Registry: Practices, Outcomes, Outcome Predictors

3. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors

4. International workshop on immune tolerance induction: consensus recommendations

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors;Thrombosis Research;2024-10

2. Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis;Research and Practice in Thrombosis and Haemostasis;2023-01

3. Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy;International Journal of Hematology;2022-05-03

4. octanate®: over 20 years of clinical experience in overcoming challenges in haemophilia A treatment;Therapeutic Advances in Hematology;2020-01

5. Hemophilia A with inhibitor: Immune tolerance induction (ITI) in the mirror of time;Transfusion and Apheresis Science;2019-10